Åsberg A - Search Results

1

Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus.

Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, Bollerslev J, Hartmann A, Åsberg A, Jenssen T. Halden TAS, et al. Among authors: asberg a. Diabetes Care. 2019 Jun;42(6):1067-1074. doi: 10.2337/dc19-0093. Epub 2019 Mar 12. Diabetes Care. 2019. PMID: 30862658 Clinical Trial.

2

Quantification of mRNA levels of endothelin receptor subtypes and preproEndothelin-1 in renal needle biopsies by competitive reverse transcriptase polymerase chain reaction.

Asberg A, Hartmann A, Attramadal H. Asberg A, et al. Scand J Clin Lab Invest. 1998 Jul;58(4):299-306. doi: 10.1080/00365519850186472. Scand J Clin Lab Invest. 1998. PMID: 9741817

3

Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.

Asberg A, Christensen H, Hartmann A, Berg KJ. Asberg A, et al. Clin Transplant. 1998 Oct;12(5):363-70. Clin Transplant. 1998. PMID: 9787942

4

Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.

Sagedal S, Asberg A, Hartmann A, Bergan S, Berg KJ. Sagedal S, et al. Among authors: asberg a. Clin Transplant. 1998 Dec;12(6):553-6. Clin Transplant. 1998. PMID: 9850449

5

Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine A based immunosuppression.

Asberg A, Attramadal H, Midtvedt K, Sund S, Hartmann A, Berg KJ. Asberg A, et al. Transplantation. 1999 Apr 15;67(7):1056-60. doi: 10.1097/00007890-199904150-00020. Transplantation. 1999. PMID: 10221493

6

Nonspecific microvascular vasodilation during iontophoresis is attenuated by application of hyperosmolar saline.

Asberg A, Holm T, Vassbotn T, Andreassen AK, Hartmann A. Asberg A, et al. Microvasc Res. 1999 Jul;58(1):41-8. doi: 10.1006/mvre.1999.2153. Microvasc Res. 1999. PMID: 10388602

7

Pharmacokinetic interactions between microemulsion formulated cyclosporine A and diltiazem in renal transplant recipients.

Asberg A, Christensen H, Hartmann A, Carlson E, Molden E, Berg KJ. Asberg A, et al. Eur J Clin Pharmacol. 1999 Jul;55(5):383-7. doi: 10.1007/s002280050644. Eur J Clin Pharmacol. 1999. PMID: 10456488

8

Each administration of cyclosporin A enhances skin microvascular reactivity in renal transplant recipients.

Asberg A, Berg KJ, Hartmann A. Asberg A, et al. Microvasc Res. 2000 Sep;60(2):81-90. doi: 10.1006/mvre.2000.2247. Microvasc Res. 2000. PMID: 10964582 Clinical Trial.

9

[Acute dialysis-dependent renal failure at the Rikshospital in 1998].

Witczak BJ, Asberg A, Hartmann A. Witczak BJ, et al. Among authors: asberg a. Tidsskr Nor Laegeforen. 2001 Apr 20;121(10):1216-9. Tidsskr Nor Laegeforen. 2001. PMID: 11402747 Free article. Norwegian.

10

Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients.

Asberg A, Midtvedt K, Vassbotn T, Hartmann A. Asberg A, et al. Nephrol Dial Transplant. 2001 Jul;16(7):1465-70. doi: 10.1093/ndt/16.7.1465. Nephrol Dial Transplant. 2001. PMID: 11427642 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

420 results

Search Page

Filters